Merck&Co earnings beat by $0.12, revenue topped estimates By Investing.com

<p> <br />
</p>
<div>
<div>
<img decoding="async" alt="Merck&amp;Co earnings beat by $0.12, revenue topped estimates" id="carouselImage" src="https://i-invdn-com.investing.com/news/LYNXNPEC0Q1B5_L.jpg" style="visibility:hidden" /><br />
<span>© Reuters. Merck&amp;Co earnings beat by $0.12, revenue topped estimates</span><br />
<i class="imgGrad"/>
</div>
<p>Investing.com – Merck&amp;Co (NYSE: ) reported second quarter EPS of $-2.06, $0.12 better than the analyst estimate of $-2.18. Revenue for the quarter came in at $15B versus the consensus estimate of $14.43B.</p>
<h2>Guidance</h2>
<p>Merck&amp;Co sees FY 2023 EPS of $2.95-$3.05 versus the analyst consensus of $2.60.</p>
<p>Merck&amp;Co sees FY 2023 revenue of $58.60B-$59.60B versus the analyst consensus of $53.20B.</p>
<p>Merck&amp;Co’s stock price closed at $106.65. It is down -9.13% in the last 3 months and up 21.73% in the last 12 months.</p>
<p>Merck&amp;Co saw 0 positive EPS revisions and 18 negative EPS revisions in the last 90 days. See Merck&amp;Co’s stock price’s past reactions to earnings here.</p>
<p dir="ltr">According to InvestingPro, Merck&amp;Co’s Financial Health score is “great performance”. </p>
<p dir="ltr">Check out Merck&amp;Co’s , and Merck&amp;Co’s financials here.</p>
<p dir="ltr">Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar</p>
</div>
<p><br />
<br /><a href="https://www.investing.com/news/stock-market-news/merckco-earnings-beat-by-012-revenue-topped-estimates-3140254">Source link </a></p><p>The post <a href="https://forextraderhub.com/merckco-earnings-beat-by-0-12-revenue-topped-estimates-by-investing-com.html">Merck&Co earnings beat by $0.12, revenue topped estimates By Investing.com</a> first appeared on <a href="https://forextraderhub.com">Forex Trader Hub</a>.</p>